Role of the Histone Modifier KDM6A in Stem Cell Differentiation
组蛋白修饰剂 KDM6A 在干细胞分化中的作用
基本信息
- 批准号:8185689
- 负责人:
- 金额:$ 29.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectArchitectureBiochemicalBiologicalBiological ProcessCell LineCellsChromatinComplexDataDevelopmentES Cell LineEmbryonal CarcinomaEnzymesEpigenetic ProcessEventGene ActivationGene ClusterGene ExpressionGene Expression RegulationGene SilencingGene TargetingGenesGenetic TranscriptionHistone H3HistonesHomeobox GenesHumanIndividualLinkLocationLysineMalignant NeoplasmsMapsMediatingMedicalMethylationMethyltransferaseModificationMolecularNeuronal DifferentiationNeuronsNucleic Acid Regulatory SequencesPlayProcessPromoter RegionsProteinsResolutionRoleScienceSignal TransductionSiteStem Cell ResearchStem cellsTherapeuticTherapeutic UsesTransactivationTranscriptional ActivationTranscriptional RegulationTretinoinUndifferentiatedanticancer researchbasecancer stem cellcell typechromatin immunoprecipitationcofactordemethylationdesignembryonic stem cellgene repressiongenome-widehuman stem cellsinnovationinsightleukemianovelpromoterreconstitutionresearch studysmall moleculestem cell differentiation
项目摘要
DESCRIPTION (provided by applicant): Histone lysine (K) methylation has emerged as a key epigenetic mark associated with transcriptional regulation of gene expression. In particular, trimethylation at histone H3 lysine 27 (H3K27me3) is linked with gene silencing, whereas trimethylation at histone H3 lysine 4 (H3K4me3) is highly correlated with gene activation. H3K4me3 and H3K27me3 occupy and affect 68-75% and 7%, respectively, of all human gene- regulatory regions in embryonic stem cells and play critical roles in numerous epigenetic processes, including stem cell differentiation. Interestingly, these two types of methylation with opposing roles co-occupy many promoter regions, forming so-called bivalent domains that can be resolved to monovalent domains containing only H3K4me3 during cellular differentiation. Bivalent domains are transcriptionally inactive, indicating a dominant role for H3K27me3 over H3K4me3. Recently, we identified the H3K27 demethylase KDM6A (also called UTX), a long-sought histone methylation modifier that up-regulates gene expression by demethylating H3K27me3. Our long-term objective is to define the epigenetic role of KDM6A in stem cell differentiation. Our KDM6A knockdown experiments indicate that KDM6A acts as a key epigenetic regulator for retinoic acid- induced differentiation of the human stem cell line NT2/D1. Importantly, we previously showed that KDM6A interacts with the H3K4 methyltransferases mixed-lineage leukemia (MLL) 3/4 in a histone modifier complex. Therefore, the KDM6A complex is able to catalyze enzymatic processes for both H3K4 methylation and H3K27 demethylation by which bivalent domains can be resolved to monovalent domains. Consistent with this, our additional preliminary data indicate that in both NT2/D1 and the ES cell line H9, KDM6A contributes to the resolution of bivalent domains at the promoters of several key development/differentiation-specific HOX genes. Based on these exciting preliminary results, our central hypothesis is that KDM6A plays an essential role in stem cell differentiation by modifying key epigenetic signatures, such as bivalent domains, in cooperation with its associated proteins. The focus of this proposed study is on understanding the functions of KDM6A and its associated proteins in mediating stem cell differentiation and their roles in modifying epigenetic signatures of stem cells. Here, we propose the following three specific aims: 1) Characterize the role of KDM6A in mediating stem cell differentiation; 2) Determine the role of KDM6A in modifying bivalent domains; and 3) Define the roles of the KDM6A-associated proteins in KDM6A-mediated cellular differentiation. These studies will uncover the unprecedented roles for the epigenetic modifier KDM6A and its cofactor proteins in stem cell differentiation and are fundamental to our understanding at the molecular level of how key epigenetic signatures, such as bivalent domains, are modified during stem cell differentiation.
PUBLIC HEALTH RELEVANCE: The studies proposed here are designed to provide molecular mechanistic insights into how the differentiation of stem cells is mediated by the epigenetic modifier KDM6A and its partner proteins and how bivalent domains, a key epigenetic signature of stem cells, are resolved in such epigenetic event. Given that stem cells have numerous potential therapeutic and medical uses, a better understanding of the molecular basis underlying the lineage commitment of stem cells may enable the design of a safe, practical strategy for the therapeutic use of stem cells. In addition, our findings will likely be applicable to the pharmacological manipulation of the lineage commitment of stem cells involving small molecule modulators of KDM6A.
描述(由申请人提供):组蛋白赖氨酸(K)甲基化已成为与基因表达转录调控相关的关键表观遗传标记。特别是,组蛋白 H3 赖氨酸 27 (H3K27me3) 的三甲基化与基因沉默相关,而组蛋白 H3 赖氨酸 4 (H3K4me3) 的三甲基化与基因激活高度相关。 H3K4me3 和 H3K27me3 分别占据并影响胚胎干细胞中所有人类基因调控区的 68-75% 和 7%,并在包括干细胞分化在内的许多表观遗传过程中发挥关键作用。有趣的是,这两种作用相反的甲基化共同占据许多启动子区域,形成所谓的二价结构域,在细胞分化过程中可以解析为仅包含 H3K4me3 的单价结构域。二价结构域在转录上不活跃,表明 H3K27me3 相对于 H3K4me3 具有主导作用。最近,我们鉴定了 H3K27 去甲基化酶 KDM6A(也称为 UTX),这是一种长期寻找的组蛋白甲基化修饰剂,可通过使 H3K27me3 去甲基化来上调基因表达。我们的长期目标是确定 KDM6A 在干细胞分化中的表观遗传作用。我们的 KDM6A 敲低实验表明,KDM6A 作为视黄酸诱导的人类干细胞系 NT2/D1 分化的关键表观遗传调节因子。重要的是,我们之前表明 KDM6A 与组蛋白修饰复合物中的 H3K4 甲基转移酶混合谱系白血病 (MLL) 3/4 相互作用。因此,KDM6A 复合物能够催化 H3K4 甲基化和 H3K27 去甲基化的酶促过程,通过该过程可以将二价结构域解析为单价结构域。与此一致的是,我们的额外初步数据表明,在 NT2/D1 和 ES 细胞系 H9 中,KDM6A 有助于解析几个关键发育/分化特异性 HOX 基因启动子处的二价结构域。基于这些令人兴奋的初步结果,我们的中心假设是,KDM6A 通过与其相关蛋白合作修改关键的表观遗传特征(例如二价结构域),在干细胞分化中发挥重要作用。这项研究的重点是了解 KDM6A 及其相关蛋白在介导干细胞分化中的功能及其在改变干细胞表观遗传特征中的作用。在这里,我们提出以下三个具体目标:1)表征KDM6A在介导干细胞分化中的作用; 2)确定KDM6A修饰二价结构域的作用; 3) 定义 KDM6A 相关蛋白在 KDM6A 介导的细胞分化中的作用。这些研究将揭示表观遗传修饰剂 KDM6A 及其辅因子蛋白在干细胞分化中前所未有的作用,对于我们在分子水平上理解关键表观遗传特征(例如二价结构域)在干细胞分化过程中如何被修饰至关重要。
公共健康相关性:本文提出的研究旨在提供分子机制的见解,了解干细胞的分化是如何由表观遗传修饰剂 KDM6A 及其伙伴蛋白介导的,以及二价结构域(干细胞的关键表观遗传特征)如何在这种分化中得到解决。表观遗传事件。鉴于干细胞具有许多潜在的治疗和医学用途,更好地了解干细胞谱系定型的分子基础可能有助于设计出安全、实用的干细胞治疗用途策略。此外,我们的研究结果可能适用于涉及 KDM6A 小分子调节剂的干细胞谱系定型的药理学操作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Min Gyu Lee其他文献
Min Gyu Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Min Gyu Lee', 18)}}的其他基金
Heterozygous KMT2D Loss and Medulloblastoma
杂合 KMT2D 缺失和髓母细胞瘤
- 批准号:
10680489 - 财政年份:2022
- 资助金额:
$ 29.86万 - 项目类别:
Role of the Histone Modifier KDM2A in Lung Cancer
组蛋白修饰剂 KDM2A 在肺癌中的作用
- 批准号:
9978728 - 财政年份:2017
- 资助金额:
$ 29.86万 - 项目类别:
Role of the Histone Modifier KDM2A in Lung Cancer
组蛋白修饰剂 KDM2A 在肺癌中的作用
- 批准号:
10220879 - 财政年份:2017
- 资助金额:
$ 29.86万 - 项目类别:
Role of the Histone Methyltransferase MLL4 in Medulloblastoma
组蛋白甲基转移酶 MLL4 在髓母细胞瘤中的作用
- 批准号:
10159217 - 财政年份:2017
- 资助金额:
$ 29.86万 - 项目类别:
Role of the Histone Methyltransferase MLL4 in Medulloblastoma
组蛋白甲基转移酶 MLL4 在髓母细胞瘤中的作用
- 批准号:
9380515 - 财政年份:2017
- 资助金额:
$ 29.86万 - 项目类别:
Role of the Histone demethylase JARID1d in Epigenetic Events of Prostate Cancer
组蛋白去甲基化酶 JARID1d 在前列腺癌表观遗传事件中的作用
- 批准号:
8449022 - 财政年份:2011
- 资助金额:
$ 29.86万 - 项目类别:
Role of the Histone demethylase JARID1d in Epigenetic Events of Prostate Cancer
组蛋白去甲基化酶 JARID1d 在前列腺癌表观遗传事件中的作用
- 批准号:
8657902 - 财政年份:2011
- 资助金额:
$ 29.86万 - 项目类别:
Role of the Histone Modifier KDM6A in Stem Cell Differentiation
组蛋白修饰剂 KDM6A 在干细胞分化中的作用
- 批准号:
8655547 - 财政年份:2011
- 资助金额:
$ 29.86万 - 项目类别:
Role of the Histone demethylase JARID1d in Epigenetic Events of Prostate Cancer
组蛋白去甲基化酶 JARID1d 在前列腺癌表观遗传事件中的作用
- 批准号:
8296574 - 财政年份:2011
- 资助金额:
$ 29.86万 - 项目类别:
Role of the Histone Modifier KDM6A in Stem Cell Differentiation
组蛋白修饰剂 KDM6A 在干细胞分化中的作用
- 批准号:
8323405 - 财政年份:2011
- 资助金额:
$ 29.86万 - 项目类别:
相似国自然基金
“共享建筑学”的时空要素及表达体系研究
- 批准号:
- 批准年份:2019
- 资助金额:63 万元
- 项目类别:面上项目
基于城市空间日常效率的普通建筑更新设计策略研究
- 批准号:51778419
- 批准年份:2017
- 资助金额:61.0 万元
- 项目类别:面上项目
宜居环境的整体建筑学研究
- 批准号:51278108
- 批准年份:2012
- 资助金额:68.0 万元
- 项目类别:面上项目
The formation and evolution of planetary systems in dense star clusters
- 批准号:11043007
- 批准年份:2010
- 资助金额:10.0 万元
- 项目类别:专项基金项目
新型钒氧化物纳米组装结构在智能节能领域的应用
- 批准号:20801051
- 批准年份:2008
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidating the Role of YAP and TAZ in the Aging Human Ovary
阐明 YAP 和 TAZ 在人类卵巢衰老中的作用
- 批准号:
10722368 - 财政年份:2023
- 资助金额:
$ 29.86万 - 项目类别:
Prader-Willi syndrome (PWS) gene-domain and AAV miniaturization for gene therapy
Prader-Willi 综合征 (PWS) 基因域和 AAV 小型化用于基因治疗
- 批准号:
10593218 - 财政年份:2023
- 资助金额:
$ 29.86万 - 项目类别:
Specificity of ABCA7-mediated lipid efflux and its effects on intracellular lipid metabolism in neural cells
ABCA7介导的脂质流出的特异性及其对神经细胞细胞内脂质代谢的影响
- 批准号:
10591201 - 财政年份:2023
- 资助金额:
$ 29.86万 - 项目类别:
An Engineered Hydrogel Platform to Improve Neural Organoid Reproducibility for a Multi-Organoid Disease Model of 22q11.2 Deletion Syndrome
一种工程水凝胶平台,可提高 22q11.2 缺失综合征多器官疾病模型的神经类器官再现性
- 批准号:
10679749 - 财政年份:2023
- 资助金额:
$ 29.86万 - 项目类别: